他美曲林
外觀
| 臨床資料 | |
|---|---|
| 其他名稱 | CP-24,441 |
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 52795-02-5 52760-47-1 |
| PubChem CID | |
| ChemSpider | |
| UNII |
|
| CompTox Dashboard (EPA) | |
| 化學資訊 | |
| 化學式 | C17H19N |
| 摩爾質量 | 237.35 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
他美曲林(英語:Tametraline,研發代號:CP-24,441),化學名1R-甲基氨基-4S-苯基-四氫萘(1R-Methylamino-4S-phenyl-tetralin),是輝瑞公司研究的一系列化合物的母體,這些化合物最終促成了舍曲林的開發[1]。
該藥物是大鼠腦突觸體中去甲腎上腺素攝取的強效抑制劑[2],可逆轉利血平誘導的小鼠失溫症,並阻斷大鼠心臟對氚代去甲腎上腺素的攝取[3]。
他美曲林是一種去甲腎上腺素-多巴胺再吸收抑制劑(NDRI)[4]。
參見
[編輯]參考文獻
[編輯]- ^ Koe BK, Weissman A, Welch WM, Browne RG. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. The Journal of Pharmacology and Experimental Therapeutics. 1983-09, 226 (3): 686–700. PMID 6310078. doi:10.1016/S0022-3565(25)21773-6.
- ^ Koe BK. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. The Journal of Pharmacology and Experimental Therapeutics. 1976-12, 199 (3): 649–61. PMID 994022. doi:10.1016/S0022-3565(25)30726-3.
- ^ Sarges R, Koe BK, Weissman A, Schaefer JP. Blockade of heart 3H-norepinephrine up-take by 4-phenyl-1-aminotetralines: implications for the active conformation of imipramine-like drugs. The Journal of Pharmacology and Experimental Therapeutics. 1974-12, 191 (3): 393–402. PMID 4427286. doi:10.1016/S0022-3565(25)30003-0.
- ^ Welch WM, Kraska AR, Sarges R, Koe BK. Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins. Journal of Medicinal Chemistry. 1984-11, 27 (11): 1508–15. PMID 6492080. doi:10.1021/jm00377a021.